.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Teva
Medtronic
McKesson
Novartis
Baxter
Deloitte
Fuji
Chinese Patent Office

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204410

« Back to Dashboard
NDA 204410 describes OPSUMIT, which is a drug marketed by Actelion Pharms Ltd and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the OPSUMIT profile page.

The generic ingredient in OPSUMIT is macitentan. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the macitentan profile page.

Summary for NDA: 204410

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:4

Pharmacology for NDA: 204410

Suppliers and Packaging for NDA: 204410

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OPSUMIT
macitentan
TABLET;ORAL 204410 NDA Actelion Pharmaceuticals US, Inc. 66215-501 66215-501-15 1 BLISTER PACK in 1 CARTON (66215-501-15) > 15 TABLET, FILM COATED in 1 BLISTER PACK
OPSUMIT
macitentan
TABLET;ORAL 204410 NDA Actelion Pharmaceuticals US, Inc. 66215-501 66215-501-30 1 BOTTLE in 1 CARTON (66215-501-30) > 30 TABLET, FILM COATED in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Oct 18, 2013TE:RLD:Yes
Regulatory Exclusivity Expiration:Oct 18, 2018
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Regulatory Exclusivity Expiration:Oct 18, 2020
Regulatory Exclusivity Use:ORPHAN DRUG EXCLUSIVITY
Patent:► SubscribePatent Expiration:Oct 12, 2022Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Federal Trade Commission
Cerilliant
Citi
Healthtrust
Chubb
Chinese Patent Office
Moodys
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot